# Pediatric Otitis Media with Effusion and Tympanostomy Tubes
## Overview
Otitis media with effusion (OME) is one of the most prevalent conditions in childhood, affecting 90% of children by school age. Persistent OME with associated hearing loss is the most common indication for tympanostomy tube placement, the most frequently performed ambulatory surgery in children. Updated AAO-HNS guidelines provide an evidence-based framework for observation, hearing assessment, and surgical intervention.
## Pathophysiology
Eustachian tube dysfunction is the primary mechanism. Pediatric Eustachian tube: shorter, more horizontal, less efficient mucociliary clearance. Adenoid hypertrophy contributes to Eustachian tube obstruction and serves as a biofilm reservoir. Negative middle ear pressure from Eustachian tube obstruction leads to transudation of fluid. May follow acute otitis media (post-AOM effusion) or develop insidiously. Biofilm formation on middle ear mucosa contributes to chronicity.
## Epidemiology
Peak incidence: 6 months to 4 years. 90% of children have OME at least once before school age, Most episodes resolve spontaneously within 3 months. Risk factors: daycare attendance, passive smoke exposure, bottle feeding (vs. breastfeeding), cleft palate, Down syndrome, craniofacial anomalies, Native American/Inuit ancestry.
## Diagnosis
### Otoscopic Findings
Dull, opacified tympanic membrane (TM), Amber or blue discoloration. Retracted TM with visible landmarks (short process of malleus prominent). Air-fluid levels or bubbles behind the TM. Decreased TM mobility on pneumatic otoscopy (gold standard for clinical diagnosis).
### Tympanometry
Type B (flat) tympanogram: most consistent with OME. Type C (negative pressure peak): Eustachian tube dysfunction; may or may not have effusion. High sensitivity and specificity for middle ear effusion, Essential for confirming clinical diagnosis.
### Audiometry
Conductive hearing loss (CHL): typically 20-30 dB. Hearing assessment essential before making treatment decisions. Age-appropriate testing: OAE, ABR (infants), behavioral audiometry, play audiometry, conventional audiometry.
## AAO-HNS Clinical Practice Guidelines (2016 Update)
### Key Recommendations
**Distinguish OME from AOM**: OME is fluid without signs of acute infection. **Document OME duration**: distinguish acute (<3 months) from chronic (>3 months). **Watchful waiting for 3 months** from onset (or from diagnosis if onset is unclear) if hearing is not significantly affected. **Hearing testing**: recommended when OME persists 3 months or at any time language delay, learning problems, or significant hearing loss is suspected. **Pneumatic otoscopy**: recommended as the primary diagnostic method. **Not recommended**: routine screening for OME in asymptomatic children; antihistamines, decongestants, or systemic steroids for treatment; antibiotics for routine OME.
### Indications for Tympanostomy Tubes
OME persisting >= 3 months with documented hearing loss (>= 20 dB). OME persisting >= 3 months with significant symptoms (balance problems, poor school performance, behavioral issues, ear discomfort, reduced quality of life). Recurrent AOM with persistent OME between episodes, At-risk children (see below) with OME of any duration. OME with structural damage to the TM (retraction pocket, erosion).
### At-Risk Children (Lower Threshold for Intervention)
Permanent hearing loss independent of OME, Speech/language delay or disorder, Autism spectrum disorder, Craniofacial disorders (cleft palate, Down syndrome). Visual impairment or blindness (increased reliance on hearing). Developmental delay.
## Tympanostomy Tube Placement
### Technique
General mask anesthesia (brief procedure, typically 10-15 minutes). Microscopic visualization with speculum. Myringotomy: radial incision in the anteroinferior quadrant (avoids ossicles and round window). Aspiration of middle ear effusion, Tube insertion with alligator forceps or applicator. Topical antibiotic drops (ofloxacin or ciprofloxacin/dexamethasone).
### Tube Types
| Tube Type | Examples | Duration | Extrusion | Perforation Rate |
|-----------|----------|----------|-----------|-----------------|
| Short-term | Shepard grommet, Armstrong, collar button | 6-18 months | Spontaneous | 1-5% |
| Long-term (T-tube) | Goode T-tube, Per-Lee | 2-4 years | Manual removal required | Up to 15% |
**Short-term tubes**: grommet (Shepard), collar button, Armstrong; spontaneous extrusion at 6-18 months. **Long-term (T-tubes)**: flanged design; remain in place longer (2-4 years); require manual removal. Selection based on expected duration of need, prior tube history, and surgeon preference.
### Adjunct: Adenoidectomy
Consider adenoidectomy with tubes for: Age >= 4 years. Repeat tube insertion (after first set has extruded and OME recurs). Adenoid hypertrophy causing nasal obstruction. Chronic adenoiditis. Adenoidectomy reduces the need for further tube insertions by 50%. Not recommended at first tube insertion in children <4 years unless adenoid-related obstruction is present.
## Postoperative Management
Topical antibiotic drops for 3-5 days postoperatively. Water precautions: controversial; AAO-HNS states routine water precautions are NOT necessary for surface swimming; deep diving and soapy water may increase otorrhea risk. Follow-up audiogram to confirm hearing improvement, Follow-up at 6-12 month intervals until tubes extrude, Monitor for complications.
## Complications
### Otorrhea
Most common complication (10-26%). Acute: usually from water exposure or upper respiratory infection. Management: topical antibiotic-steroid drops (ciprofloxacin/dexamethasone); avoid systemic antibiotics and ototopical aminoglycosides. Persistent otorrhea (>4 weeks): culture-directed topical therapy; consider tube removal if refractory.
### Premature Tube Extrusion
Extrusion <6 months; may require replacement if OME recurs.
### Persistent TM Perforation
Occurs in 1-5% of short-term tubes; up to 15% for T-tubes, Observation initially (may close spontaneously). Myringoplasty (paper patch or fat graft) or formal tympanoplasty if persistent after 6-12 months.
### Tympanosclerosis
White calcium deposits in the TM (myringosclerosis), Very common (up to 50%); usually clinically insignificant, Rarely affects hearing.
### Other
Granulation tissue around tube. Tube migration (medial displacement into middle ear): rare; may require removal. Cholesteatoma: extremely rare; monitor for retraction pockets.
Otoscopic findings in otitis media with effusion. Four panels showing: Panel A: Normal tympanic membrane with translucent appearance, visible cone of light, and malleus landmarks. Panel B: OME with amber-colored effusion visible behind a retracted TM and prominent short process of the malleus. Panel C: OME with air-fluid level and air bubbles visible behind the TM. Panel D: Bilateral tympanostomy tubes in place with patent lumens and clear middle ear spaces. Each panel includes a corresponding tympanogram tracing (Type A normal, Type B flat for OME, and Type A post-tube).
Tympanostomy tube insertion technique. Step-by-step illustration showing: (1) Microscopic view of the TM with the anteroinferior quadrant marked for myringotomy. (2) Radial myringotomy incision using a myringotomy blade. (3) Aspiration of middle ear effusion with a suction tip. (4) Insertion of a grommet-type tube using alligator forceps through the myringotomy. (5) Final position with the tube seated in the TM, flanges visible on both sides. An inset shows cross-sectional anatomy of the middle ear with the tube ventilating the middle ear space. Common tube types are illustrated: Shepard grommet, Armstrong, and T-tube with relative sizes.
Clinical decision algorithm for pediatric OME based on AAO-HNS guidelines. Flowchart begins with OME diagnosed by pneumatic otoscopy and/or tympanometry. First decision: is the child at risk (hearing loss, speech delay, craniofacial anomaly)? At-risk children: lower threshold for tubes and hearing testing. Non-at-risk: observe for 3 months. After 3 months: reassess with hearing test. If CHL >= 20 dB or significant symptoms: tympanostomy tubes +/- adenoidectomy. If CHL < 20 dB: continued observation with repeat testing every 3-6 months. Re-evaluation pathway for tube extrusion with recurrent OME: consider repeat tubes with adenoidectomy if age >= 4 years.
## Clinical Pearls
Pneumatic otoscopy is the single most important clinical skill for diagnosing OME; decreased TM mobility is more reliable than color or position changes alone. Most OME episodes resolve spontaneously within 3 months; watchful waiting with serial hearing assessment is appropriate for uncomplicated cases. Antihistamines, decongestants, and systemic steroids have no role in the treatment of OME; they are specifically not recommended by the AAO-HNS guidelines. At-risk children (cleft palate, Down syndrome, speech delay, baseline hearing loss) should have a lower threshold for tube placement because they are more vulnerable to the effects of conductive hearing loss on development. Adenoidectomy should be considered at the time of repeat tube insertion (after extrusion of the first set) in children >= 4 years; it reduces the need for additional tube procedures by approximately 50%. Topical antibiotic drops (fluoroquinolone-based) are first-line for tube otorrhea; systemic antibiotics and aminoglycoside ototopicals should be avoided.
## References
- Rosenfeld RM, Shin JJ, Schwartz SR, et al. "Clinical practice guideline: otitis media with effusion (update)." *Otolaryngol Head Neck Surg*. 2016;154(1 Suppl):S1-S41.
- Kay DJ, Nelson M, Rosenfeld RM. "Meta-analysis of tympanostomy tube sequelae." *Otolaryngol Head Neck Surg*. 2001;124(4):374-380.
- Hellstrom S, Groth A, Jorgensen F, et al. "Ventilation tube treatment: a systematic review of the literature." *Otolaryngol Head Neck Surg*. 2011;145(3):383-395.
- Paradise JL, Feldman HM, Campbell TF, et al. "Tympanostomy tubes and developmental outcomes at 9 to 11 years of age." *N Engl J Med*. 2007;356(3):248-261.